Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Non-Invasive Monitoring Systems, Inc. has entered into an agreement and plan of merger with Gravitics, Inc., with Gravitics merger sub, Inc. as the acquisition subsidiary. The filing is dated March 6, 2026 and references a closing process, conversion of company securities, and treatment of dissenting shares, fractional shares, stock options, and warrants.
The merger agreement includes representations and warranties covering organizational status, capitalization, authorization, compliance with laws, financial statements, intellectual property, employees, permits, and FDA-related matters. It also sets covenants around closing efforts, regulatory notices and consents, and filing obligations for post-merger reporting.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026